Related Experiment Video
Updated: Oct 9, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Palliative-Oriented Referral and Advanced Vulnerability in Very Old Patients Hospitalised for Acute Heart Failure
Rémi Esser1, Clémence Pépin1, Jennifer Corny2
1Department of Cardiogeriatrics, Hôpital La Porte Verte, Versailles.
Background:
Palliative-oriented referral in very old patients hospitalised for acute heart failure (HF) is common in cardiogeriatric practice, but their clinical profile and outcomes remain poorly described. We used referral to the French Identified Palliative Care Bed model, Lits Identifiés de Soins Palliatifs (LISP), as a real-world marker.
Methods:
This retrospective single-centre study included patients aged >65 years discharged after acute HF hospitalisation from a cardiogeriatric unit between 1 January and 24 September 2025. Patients who died during the index stay, objected to secondary data use, or had missing/non-interpretable 3-month follow-up were excluded.
Results:
Among 604 patients analysed (mean age 86.9 ± 7.1 years; 52% women), 106 had LISP referral. In exploratory multivariable logistic regression, LISP referral was associated with lower Activities of Daily Living score [odds ratio (OR) 0.45, 95% confidence interval (CI) 0.37-0.55; P < 0.001], major neurocognitive disorders (OR 2.98, 95% CI 1.73-5.13; P < 0.001), higher log-transformed discharge NT-proBNP (OR 1.35, 95% CI 1.08-1.69; P = 0.008), lower SGLT2 inhibitor use among patients with LVEF >50% (OR 0.49, 95% CI 0.27-0.88; P = 0.017), and fewer discharge medications (OR 0.88, 95% CI 0.79-0.97; P = 0.011). LISP referral was associated with higher mortality and lower 6-month survival (47.6% vs. 79.5%).
Conclusion:
LISP referral identified very old patients with acute HF, advanced multidimensional vulnerability, higher NT-proBNP levels, and high short-term mortality. It should be interpreted as a clinician-assigned marker, not as a causal determinant of prognosis.
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy VI: Nursing Management